1 – 10 of 25
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia
Sandén, Carl LU ; Landberg, Niklas LU
; Peña-Martínez, Pablo
LU
; Thorsson, Hanna
LU
; Daga, Shruti
LU
; Puente-Moncada, Noelia
LU
; Rodriguez-Zabala, Maria
LU
; von Palffy, Sofia
LU
; Rissler, Marianne
LU
and Lazarevic, Vladimir
LU
, et al.
(2025)
In Nature Cancer
- Contribution to journal › Article
-
Mark
Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition : Results from a Prospective Cohort Study
Tesi, Bianca ; Robelius, Anna ; Baskin, Berivan ; Lazarevic, Vladimir LU
; Deneberg, Stefan
; Höglund, Martin
; Fogelstrand, Linda
; Ungerstedt, Johanna
; Pandzic, Tatjana
and Tobiasson, Magnus
, et al.
(2025)
In Clinical Cancer Research
31(14).
p.3062-3071
- Contribution to journal › Article
- 2024
-
Mark
TLE3 Is a Novel Fusion Partner of JAK2 in Myeloid/Lymphoid Neoplasm With Eosinophilia Responding to JAK2 Inhibition
Lazarevic, Vladimir LU
; Lilljebjörn, Henrik
LU
; Olsson-Arvidsson, Linda
LU
; Orsmark-Pietras, Christina
LU
and Ågerstam, Helena
LU
(2024)
In Genes Chromosomes and Cancer
63(8).
p.1-8
- Contribution to journal › Article
-
Mark
Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases
Thorsson, Hanna LU ; Henningsson, Rasmus LU ; Puente-Moncada, Noelia LU ; Peña-Martínez, Pablo LU ; Sjöström, Ludvig LU ; Ågerstam, Helena LU ; Sandén, Carl LU ; Rissler, Marianne LU ; Castor, Anders LU
and Marquart, Hanne
, et al.
(2024)
In Blood
144(13).
p.1399-1411
- Contribution to journal › Article
-
Mark
How to manage patients with germline DDX41 variants : Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms
- Contribution to journal › Article
- 2023
-
Mark
The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
von Palffy, Sofia LU ; Thorsson, Hanna LU ; Peña-Martínez, Pablo LU ; Puente-Moncada, Noelia LU ; Sandén, Carl LU ; Blom, Anna M LU
; Henningsson, Rasmus
LU
; Juliusson, Gunnar
LU
; King, Ben
LU
and Landberg, Niklas
LU
, et al.
(2023)
In Blood Advances
7(7).
p.1204-1218
- Contribution to journal › Article
-
Mark
IL1RAP is expressed in several subtypes of pediatric acute lymphoblastic leukemia and can be used as a target to eliminate
ETV6::RUNX1-positive leukemia cells in preclinical models.
Ågerstam, Helena LU ; Lilljebjörn, Henrik LU
; Rissler, Marianne
LU
; Sandén, Carl
LU
and Fioretos, Thoas
LU
(2023)
In Haematologica
108(2).
p.599-604
- Contribution to journal › Article
- 2020
-
Mark
Clonal competition within complex evolutionary hierarchies shapes AML over time
Sandén, Carl LU ; Lilljebjörn, Henrik LU
; Orsmark Pietras, Christina
LU
; Henningsson, Rasmus
LU
; Saba, Karim H.
LU
; Landberg, Niklas
LU
; Thorsson, Hanna
LU
; von Palffy, Sofia
LU
; Peña-Martinez, Pablo
LU
and Högberg, Carl
LU
, et al.
(2020)
In Nature Communications
11(1).
- Contribution to journal › Article
- 2019
-
Mark
FLT3
N676K
drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis
Hyrenius-Wittsten, Axel LU ; Pilheden, Mattias LU ; Falqués-Costa, Antoni LU
; Eriksson, Mia
LU
; Sturesson, Helena
LU
; Schneider, Pauline
; Wander, Priscilla
; Garcia-Ruiz, Cristian
LU
; Liu, Jian
and Ågerstam, Helena
LU
, et al.
(2019)
In Leukemia
33(9).
p.2310-2314
- Contribution to journal › Letter
- 2018
-
Mark
CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting
Landberg, Niklas LU
; von Palffy, Sofia
LU
; Askmyr, Maria
LU
; Lilljebjörn, Henrik
LU
; Sandén, Carl
LU
; Rissler, Marianne
LU
; Mustjoki, Satu
; Hjorth-Hansen, Henrik
; Richter, Johan
LU
and Ågerstam, Helena
LU
, et al.
(2018)
In Haematologica
103(3).
p.447-455
- Contribution to journal › Article